ArticleBritish journal of cancer2021

Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway.

Lehe Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.